Research by David Dewei Yang et al. indicated that in patients with localized or locally advanced PCa and GS ≥ 8, treated with definitive RT, ADT was associated with decreased ACM in patients with PSA > 2.5 ng/mL. This evidence concerns the gene KLK3 and posterior cortical atrophy.